Cargando…
Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015
BACKGROUND: Medical therapy for multiple sclerosis (MS) is expensive. Quantifying the burden of MS is fundamental for health-care planning and the allocation of resources for the management of MS. This study provides current national estimates of prevalence, incidence, mortality, and costs of MS in...
Autores principales: | Blozik, Eva, Rapold, Roland, Eichler, Klaus, Reich, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677381/ https://www.ncbi.nlm.nih.gov/pubmed/29138568 http://dx.doi.org/10.2147/NDT.S143180 |
Ejemplares similares
-
Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011
por: Huber, Carola A, et al.
Publicado: (2014) -
Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: results of a pragmatic consensus process
por: Blozik, Eva, et al.
Publicado: (2018) -
Prescription of potentially inappropriate medication in older persons in Switzerland: does the dispensing channel make a difference?
por: Blozik, Eva, et al.
Publicado: (2015) -
Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland
por: Reich, Oliver, et al.
Publicado: (2017) -
Anti-VEGF treatment patterns and associated health care costs in Switzerland: findings using real-world claims data
por: Reich, Oliver, et al.
Publicado: (2015)